XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.25.1

Earnings per Common Share | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 197.0 |  |  | $ | 140.1 |  |  |  |  |
Less: Net income attributable to noncontrolling interests included in continuing operations | (45.0) |  |  | (26.3) |  |  |  |  |
Less: Income allocated to participating securities | (0.4) |  |  | (0.8) |  |  |  |  |
Income from continuing operations attributable to Encompass Health common shareholders | 151.6 |  |  | 113.0 |  |  |  |  |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.5) |  |  | (1.3) |  |  |  |  |
Net income attributable to Encompass Health common shareholders | $ | 151.1 |  |  | $ | 111.7 |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 100.5 |  |  | 99.8 |  |  |  |  |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.50 |  |  | $ | 1.13 |  |  |  |  |
Discontinued operations | — |  |  | (0.01) |  |  |  |  |
Net income | $ | 1.50 |  |  | $ | 1.12 |  |  |  |  |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 197.0 |  |  | $ | 140.1 |  |  |  |  |
Less: Net income attributable to noncontrolling interests included in continuing operations | (45.0) |  |  | (26.3) |  |  |  |  |
Income from continuing operations attributable to Encompass Health common shareholders | 152.0 |  |  | 113.8 |  |  |  |  |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.5) |  |  | (1.3) |  |  |  |  |
Net income attributable to Encompass Health common shareholders | $ | 151.5 |  |  | $ | 112.5 |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 102.1 |  |  | 102.2 |  |  |  |  |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.48 |  |  | $ | 1.11 |  |  |  |  |
Discontinued operations | — |  |  | (0.01) |  |  |  |  |
Net income | $ | 1.48 |  |  | $ | 1.10 |  |  |  |  |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Basic weighted average common shares outstanding | 100.5 |  |  | 99.8 |  |  |  |  |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.6 |  |  | 2.4 |  |  |  |  |
Diluted weighted average common shares outstanding | 102.1 |  |  | 102.2 |  |  |  |  |
See Note 16, Earnings per Common Share, to the consolidated financial statements accompanying the 2024 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration